Skip to main content

Advertisement

SpringerLink
Log in

Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson’s disease

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B, Paleacu D, Korczyn AD (2001) Freezing of gait in patients with advanced Parkinson’s disease. J Neural Transm 108:53–61

    Article  PubMed  CAS  Google Scholar 

  2. Giladi N (2008) Medical treatment of freezing of gait. Mov Disord 23:482–488

    Article  Google Scholar 

  3. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434

    Article  PubMed  Google Scholar 

  4. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ (2008) Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 70:2241–2247

    Article  PubMed  CAS  Google Scholar 

  5. Moore O, Peretz C, Giladi N (2007) Freezing of gait affects quality of life of peoples with Parkinson’s disease beyond its relationships with mobility and gait. Mov Disord 22:2192–2195

    Article  PubMed  Google Scholar 

  6. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider G, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. New Engl J Med 355:896–908

    Article  PubMed  CAS  Google Scholar 

  7. Moreau C, Defebvre L, Destee A, Bleuse S, Clement F, Blatt JL, Krystkowiak P, Devos D (2008) STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 71:80–84

    Article  PubMed  CAS  Google Scholar 

  8. Ferraye MU, Debu B, Fraix V, Goetz L, Ardouin C, Yelnik J, Henry-Lagrange C, Seigneuret E, Piallat B, Krack P, Le Bas JF, Benabid AL, Chabardes S, Pollak P (2010) Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain 133:205–214

    Article  PubMed  CAS  Google Scholar 

  9. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130:1596–1607

    Article  PubMed  Google Scholar 

  10. Moro E, Hamani C, Poon YY, Al-Khairallah T, Dostrovsky JO, Hutchison WD, Lozano AM (2010) Unilateral pedunculopontine stimulation improves falls in Parkinson’s disease. Brain 133:215–224

    Article  PubMed  Google Scholar 

  11. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7:2–13

    Article  PubMed  CAS  Google Scholar 

  12. Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe WH, Stocchi F, Tolosa E (2009) Validation of the freezing of gait questionnaire in patients with Parkinson’s disease. Mov Disord 24:655–661

    Article  PubMed  Google Scholar 

  13. Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML (2009) Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson’s disease. Brain 132:172–184

    Article  PubMed  CAS  Google Scholar 

  14. Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ (2004) Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 15:2621–2624

    Article  PubMed  Google Scholar 

  15. Aziz TZ, Davies L, Stein J, France S (1998) The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia. Br J Neurosurg 12:245–249

    Article  PubMed  CAS  Google Scholar 

  16. Winn P (2006) How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 248:234–250

    Article  PubMed  Google Scholar 

  17. Breit S, Lessmann L, Unterbrink D, Popa RC, Gasser T, Schulz JB (2006) Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model. Eur J neurosci 24:2275–2282

    Article  PubMed  CAS  Google Scholar 

  18. Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, Dormont D, Cornu P, Pidoux B, Samson Y, Agid Y (1999) Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 340(19):1476–1480

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Daniel Weiss received funding from Medtronic GmbH and from the Medical Faculty of University of Tübingen (AKF 259-0-0). Christian Plewnia was supported by grants from the German Research Council [DFG PL 525/11] and from the University of Tübingen [AKF 238-0-0]. Alireza Gharabaghi was supported by grants from the German Research Council [DFG GH 94/2-1, DFG EC 307], Federal Ministry for Education and Research [Bernstein 01GQ0761, BMBF 16SV3783], Medtronic Research Grant, European Union [ERC 2276329], and the University of Tübingen [AKF 238-0-0]. Rejko Krüger is supported by grants of the German Research Council [DFG; KR2119/3-2, the Michael J Fox Foundation, the Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134] and from the Medical Faculty of the University of Tübingen [AKF 238-0-0].

Conflict of interest

D. Weiss received speaker’s honoraria and travel grants from Medtronic and Solvay. T. Wächter has received speaker’s honoraria and travel grants from Medtronic, Schwarz Pharma, and Solvay. S. Breit, C. Plewnia, and A. Gharabaghi reports no conflict of interest. R. Krüger received speaker’s honoraria and/or travel grants from UCB Pharma, Cephalon, Abott Pharma, Takeda Pharma, and Medtronic.

Author information

Authors and Affiliations

  1. Department for Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany

    Daniel Weiss, Sorin Breit, Tobias Wächter & Rejko Krüger

  2. Department of Psychiatry, Neurophysiology and Interventional Psychiatry, University of Tübingen, Tübingen, Germany

    Christian Plewnia

  3. Werner Reichardt Centre for Integrative Neuroscience and Department of Neurosurgery, University of Tübingen, Tübingen, Germany

    Alireza Gharabaghi

Authors
  1. Daniel Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sorin Breit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tobias Wächter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian Plewnia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alireza Gharabaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rejko Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rejko Krüger.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 134 kb)

Supplementary material 2 (MPG 22553 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, D., Breit, S., Wächter, T. et al. Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson’s disease. J Neurol 258, 1183–1185 (2011). https://doi.org/10.1007/s00415-011-5906-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-5906-3

Keywords

Search

Navigation